← Open Payments lookup

JOSEPH RENZI: Open Payments

NPI 1043255003 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,633 in 113 payments from 32 companies in 2025. Trend: 2023 $3,158 · 2024 $3,515 · 2025 $2,633

Food & beverage: $2,633
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$339
Braeburn Inc.9$289
Novo Nordisk Inc13$283
ABBVIE INC.18$229
SHIELD THERAPEUTICS INC5$205
Kowa Pharmaceuticals America, Inc.6$174
Aimmune Therapeutics, Inc.4$102
Astellas Pharma US Inc4$101
Lundbeck LLC4$87
Lilly USA, LLC3$76

Products named: BRIXADI, ACCRUFER, FARXIGA, ZORYVE, REXULTI, VRAYLAR, Veozah, ZENPEP.

Industry payments across PA — which companies pay providers there.